Appointment booking for Dr. Goddard Lainjo, MD is currently not available.Dr. Goddard Lainjo, MD has not yet fully activated their profile on DiabetesIQ.
Dr. Goddard Lainjo, MD (he/him) is a Rheumatologist in Middletown, NY with over 19 years of experience. What is your opinion of Dr. Goddard Lainjo, MD? Rate this provider below so other people can make informed decision.
Gender
Male
Experience
Over 19 Years of Experience
Languages Spoken
English
Accepted Insurances
Medicare
Payments Received
Many providers receive payments from medical companies such as pharmaceutical companies and medical device companies. These payments can range from small amounts for meals to large consulting fees. We provide this information in order to make healthcare system more transparent. Between 2014 and 2020 Dr. Goddard Lainjo, MD has received over $6,509 which includes payments from the following companies:
$1,110.27 from Pfizer Inc.
$691.44 from Celgene Corporation
$628.83 from AbbVie, Inc.
$508.66 from Amgen Inc.
$503.65 from Genentech USA, Inc.
$440.01 from Mallinckrodt LLC
$334.89 from Janssen Biotech, Inc.
$330.96 from Takeda Pharmaceuticals America, Inc.
$215.85 from GlaxoSmithKline, LLC.
$213.75 from Mallinckrodt Enterprises LLC
$182.60 from LILLY USA, LLC
$165.81 from Questcor Pharmaceuticals
$160.60 from Par Pharmaceutical, Inc.
$147.25 from UCB, Inc.
$142.20 from Genentech, Inc.
$114.19 from Mallinckrodt Hospital Products Inc.
$107.32 from Radius Health, Inc.
$101.86 from E.R. Squibb & Sons, L.L.C.
$97.14 from Purdue Pharma L.P.
$61.02 from Antares Pharma, Inc.
Payments received by Dr. Goddard Lainjo, MD were from the following categories:
Do you have any questions about your diabetes condition or general questions about diabetes? You can now post those questions in DiabetesIQ Forum and have our diabetes experts answer your questions for FREE! Yes, there is absolutely no catch! - Registration only takes a few seconds and it's FREE. No credit card needed. You can ask any number of diabetes questions, all for FREE! Register today and join the conversation!